Good vision can mask active proliferative disease. This Visually Speaking case shows how widefield imaging revealed critical peripheral clues in a patient with diabetic retinopathy. Read more here: ow.ly/P2YO50ZjoMB #RetinaToday #OCTA #DiabeticRetinopathy

Which patients with geographic atrophy may be appropriate candidates for complement inhibition? Explore key considerations for treatment selection, including disease characteristics and patient factors: ow.ly/rVgN50ZRzmV This article is available to our ex-US audiences.

Up to 35% of patients with DME gained fewer than 5 letters at 12 weeks on monthly aflibercept 2 mg in the Protocol T early analysis. Where could TKIs fit? ow.ly/yJZh50ZRyio #Ophthalmology

👁️ This World Retina Day, we celebrate the advances shaping retinal care. But can we do more to detect diabetic eye disease earlier? Experts from around the world explore the challenges of global screening—and the opportunities ahead. Read more: ow.ly/nvpM50ZKY1W

Can OCTA predict DR progression? Kallista Zhuang, BA, Shinji Kakihara, MD, PhD, and Amani A. Fawzi, MD review the evidence in Retina Today's Sept issue. Read: ow.ly/VBiH50ZQ9yl #RetinaResearch #Ophthalmology

We're thrilled to be in sunny Los Angeles ☀️ for a fantastic scientific program at the #RetinaSociety2026 annual meeting! #retina

From SOL-1 and TRUCKEE to OCU410 in GA and Stargardt and real-world YAG data, New Retina Radio recaps key findings from #ASRS 2026, highlighting the latest advances and real-world insights in retina. Listen now: ow.ly/fsPi50ZQNq4

Nanoscope said Dr. Christine Kay will present 4-year MCO-010 data from the RESTORE trial for retinitis pigmentosa at the Retina Society meeting in Los Angeles. ow.ly/Hehg50ZPOXF"

AI's role in DME is moving from research to real-world practice. Scott Song, BA, and T.Y. Alvin Liu, MD, break down the data in this month's 𝑅𝑒𝑡𝑖𝑛𝑎 𝑇𝑜𝑑𝑎𝑦. Read: ow.ly/CXOR50ZMhAc #Ophthalmology #ClinicalPractice #AIInMedicine

In the latest episode of Formula Retina, leading surgeons explore how UNITY VCS is advancing vitreoretinal surgery. They discuss the platform’s innovative technology, intelligent fluidics, IOP control, illumination, 27-gauge vitrectomy, and more: ow.ly/U7Kb50ZEXSK

New data on AI in DME: A CFP-based screening model hit a 0.962 patient-level AUC, an AI-assisted OCT pathway cut false-positive referrals from 69.1% to 24.1%, and a multimodal model beat specialists at predicting anti-VEGF response — internally, at least. ow.ly/94hL50ZOSt6

New Retina Radio Journal Club: Barton Blackorby, MD, Katherine Talcott, MD, and Hong-Uyen Hua, MD discuss retinal perfusion, sensitivity, and function in DR. Watch: ow.ly/63yj50ZM6xv #Ophthalmology #DiabeticRetinopathy #RetinalPerfusion

Join Peter Kaiser, MD, as he reviews the newly designed AMD pipeline poster. It's sleeker, more useful, and ready to rock. Learn more here: ow.ly/tw8150ZNumK #retina #ophthalmology

How should early geographic atrophy be defined? 👁️ Sean D. Adrean, MD, FAAO, explores why lesion size alone may not tell the full story—and what clinicians should consider when identifying early GA. Read more: ow.ly/MuCv50ZNxLF

Global DR screening has come a long way, but access gaps remain. New from Retina Today, an international panel breaks down the hope and hurdles ahead. Read: ow.ly/RzP950ZM3Rn #DiabeticRetinopathy #Ophthalmology #GlobalHealth

There's still time to register for #Euretina26. Join the international retina community in Vienna (1–4 Oct) for four days of science, clinical insight and collaboration. Register now: ow.ly/r30Q50ZJv6u #ad

𝐍𝐄𝐖 𝐈𝐒𝐒𝐔𝐄: 𝑹𝒆𝒕𝒊𝒏𝒂 𝑻𝒐𝒅𝒂𝒚'𝒔 September issue takes a global look at diabetic eye disease — AI in DME, implant-based treatments, TKIs, and why DR screening access still varies so widely worldwide. Read: ow.ly/vghL50ZM0cp #Ophthalmology #MedicalResearch

Talking about the future of ophthalmology is easy. Building a meeting around it is not. Bringing together different perspectives, and creating connections. This is the challenge behind Eyenovate & Retina Futura. December 3, 2026 | FLORetina-ICOOR 2026 ow.ly/CLgm50ZKH8b #ad

Dr. Carl Danzig uses FAF and OCT on every new patient to detect clinical biomarkers that characterize GA. Listen to the podcast miniseries GA in Practice to hear what Drs. Geeta Lalwani and Murtaza Adam think about this approach. #retina Listen Here: ow.ly/FU6A50ZL2Vz

🔬 New on Retinaws: Explore complex surgical challenges, from severe PVR and diabetic TRD to suprachoroidal and scleral buckles, Ozurdex implants, nanophthalmos, macular folds, and more. Discover techniques and insights for the OR. 👁️ Watch now: ow.ly/wvU850ZJCla

What happens when a cataract progresses after PPV—and then the lens is no longer there? Read more: ow.ly/zc3H50ZKYP2 #Retina #Ophthalmology